

We read with interest the Article by Benjamin J Singer and colleagues published in The Lancet Microbe1 on the potential impact of novel drugs against schistosomiasis. The study offers valuable insights; however, a key consideration is the omission of dynamic modelling for the emergence and spread of drug resistance, which could affect long-term projections.
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet
Microbe / Infectious Research
|15th Jan, 2026
|The Lancet